These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 4784173

  • 1. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K, Uono M, Nakanishi T, Kato N, Nagao Y.
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract] [Full Text] [Related]

  • 3. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
    Serrano PA, Irigoyen M.
    Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D.
    Schweiz Med Wochenschr; 1972 Jan 22; 102(3):88-94. PubMed ID: 4551909
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F, Roth R, Ross P, Davis J.
    J Ky Med Assoc; 1971 Apr 22; 69(4):265-9. PubMed ID: 5577419
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Action of L-dopa in Parkinson's syndrome].
    Ucar S, Eiras J.
    Rev Clin Esp; 1971 Feb 15; 120(3):257-62. PubMed ID: 5568474
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT.
    Confin Neurol; 1972 Jun 07; 34(2):130-5. PubMed ID: 4666056
    [No Abstract] [Full Text] [Related]

  • 17. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U.
    Dtsch Med Wochenschr; 1972 Apr 28; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH, Markham CH, Lee JE, Treciokas LJ, Ansel RD.
    Contemp Neurol Ser; 1971 Apr 28; 8():175-201. PubMed ID: 4950056
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T.
    No To Shinkei; 1970 Dec 28; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.